Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Aardvark Therapeutics Inc...

    NASDAQ: AARD · Real-Time Price · USD
    10.48
    0.04 (0.38%)
    At close: Aug 19, 2025, 10:24 AM

    Aardvark Therapeutics Common Stock Income Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
    Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Cost of Revenue
    		 n/a 5K n/a 87K 48K 2K 25K 26K
    Gross Profit
    		 n/a -5K n/a -87K -48K -2K -25K -26K
    Operating Income
    		 -15.85M -10.47M -9.45M -5.09M -6.07M -2.17M -2.23M -1.72M
    Interest Income
    		 n/a 1.18M 717K 1M 594K 103K 118K 135K
    Pretax Income
    		 -14.37M -9.31M -8.78M -4.18M -5.45M -2.18M -2.04M -2.11M
    Net Income
    		 -14.37M -9.31M -8.78M -4.18M -5.45M -2.18M -2.04M -2.11M
    Selling & General & Admin
    		 2.7M 2.71M 1.39M 1.03M 2.03M 861K 525K 538K
    Research & Development
    		 13.14M 7.75M 8.06M 4.07M 4.03M 1.21M 1.54M 964K
    Other Expenses
    		 n/a n/a n/a n/a 14K 103K 171K 217K
    Operating Expenses
    		 15.85M 10.47M 9.45M 5.09M 6.07M 2.17M 2.23M 1.72M
    Interest Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 15.85M 10.47M 9.45M 5.09M 6.07M 2.17M 2.23M 1.72M
    Income Tax Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 21.69M 13.19M 12.91M 12.91M 2.56M 12.91M 9.73M 9.73M
    Shares Outstanding (Diluted)
    		 21.69M 13.19M 12.91M 12.91M 2.56M 12.91M 9.73M 9.73M
    EPS (Basic)
    		 -0.66 -0.71 -0.68 -0.32 -2.13 -0.17 -0.21 -0.22
    EPS (Diluted)
    		 -0.66 -0.71 -0.68 -0.32 -2.13 -0.17 -0.21 -0.22
    EBITDA
    		 -15.85M -10.47M -9.45M -5M -6.03M -2.17M -2.02M -1.48M
    EBIT
    		 -14.37M -9.31M -9.45M -5.09M -6.07M -2.17M -2.04M -1.5M
    Depreciation & Amortization
    		 n/a 5K 8K 87K 48K 2K 25K 26K

    Add to Watchlist